CSF2 and Granuloma: Using the lung biochip integrated with the granuloma model developed by Calcagno and colleagues, researchers have demonstrated that α-MSH significantly reduces key inflammatory cytokines, including IL-1β, GM-CSF, type I IFN cytokines (ISG15 and IFN-α), and IL-2 compared with untreated controls.